Grant Opportunities

NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01) – Feb 07, 2014

By Super UserApril 24, 2013No Comments

Home » NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01) – Feb 07, 2014

…

Funding Opportunity Number:	RFA-AR-14-008
Opportunity Category:	Discretionary
Funding Instrument Type:	Cooperative Agreement
Category of Funding Activity:	Health
CFDA Number:	93.846
Eligible Applicants	State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name:	HHS-NIH11
Closing Date:	Feb 07, 2014
Award Ceiling:	$150,000
Expected Number of Awards:
Creation Date:	Apr 23, 2013
Funding Opportunity Description:	This Funding Opportunity Announcement (FOA) solicits applications for research awards designed to develop new and evaluate existing clinical trial outcome instruments/measures to better assess the benefits (efficacy and effectiveness) and adverse impacts of therapies employed to treat diseases and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and subsequent evaluation of both new and existing clinically relevant and patient-important outcome instruments/measures that could be further tested in existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, monitoring, treatment or cure of diseases and injuries of interest to the NIAMS. Outcome instruments/measures should be as generalizable as possible with the ultimate aim to impact patient care.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=231335

{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-14-008.html{/iframe}

© 2024 BioHealth Innovation.